Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis
NCT03948750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2019-05-14
Summary
Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of OT is based on clinical findings, but in most cases, laboratory tests are required to confirm the etiology, especially when other diseases are suspected. The aim of this study was to evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB) with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose OT, in current practice, especially in the first three weeks.
Conditions
- Ocular Toxoplasmosis
Interventions
- PROCEDURE
-
Aqueous humour sampling
Aqueous humour sampling with Goldman-Witmer coefficient and immunoblotting
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-01
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- France
Study Locations
More Related Trials
-
Isolated Positive Toxoplasma Gondii PCR in Blood
NCT07054918 ·Status: NOT_YET_RECRUITING
-
Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
NCT07299500 ·Status: RECRUITING
-
Measuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences
NCT05860998 ·Status: UNKNOWN
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine
NCT04843917 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
TT-CMV Observational Birth Cohort Study
NCT00907686 ·Status: COMPLETED
-
New Diagnostic Approach for Congenital Toxoplasmosis
NCT03385499 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain
NCT05087277 ·Status: UNKNOWN
-
Cerebral Toxoplasmosis and AIDS
NCT00803621 ·Status: COMPLETED
-
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465 ·Status: UNKNOWN
-
Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV
NCT04434417 ·Status: COMPLETED
-
Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children
NCT06852846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.
NCT05370976 ·Status: TERMINATED ·Phase: PHASE2
-
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
NCT04934527 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
NCT07044037 ·Status: COMPLETED
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study
NCT04888793 ·Status: COMPLETED
-
Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
NCT02689700 ·Status: UNKNOWN
-
COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests
NCT04790994 ·Status: UNKNOWN
-
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19
NCT04418206 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Cytomegalovirus Fetal Infection and Disease
NCT03090841 ·Status: UNKNOWN
-
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
NCT01251744 ·Status: COMPLETED ·Phase: NA
-
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
NCT04896788 ·Status: UNKNOWN ·Phase: NA